Implementation of an iron reduction protocol in patients with peripheral vascular disease: VA cooperative study no. 410: The Iron (FE) and Atherosclerosis Study (FEAST)
Authors:
- Leo R. ZacharskiLZLeo R. Zacharski
- Bruce K. ChowBCBruce K. Chow
- Paula S. HowesPHPaula S. Howes
- Philip W. LavoriPLPhilip W. Lavori
- Galina ShamayevaGSGalina Shamayeva
- 1 September 2004
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 148 (3) , 386-392
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Effect of Iron Depletion on Cardiovascular Risk FactorsAnnals of the New York Academy of Sciences, 2002
- Beneficial effects of blood donation on high density lipoprotein concentration and the oxidative potential of low density lipoproteinAtherosclerosis, 2002
- Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver diseaseGastroenterology, 2002
- Blood Letting in High-Ferritin Type 2 DiabetesDiabetes, 2002
- Venesection therapy of insulin resistance-associated hepatic iron overloadJournal of Hepatology, 2001
- Association of age, sex, and race with body iron stores in adults: Analysis of NHANES III dataAmerican Heart Journal, 2000
- The iron (Fe) and atherosclerosis study (FeAST): A pilot study of reduction of body iron stores in atherosclerotic peripheral vascular diseaseAmerican Heart Journal, 2000
- Lowering of body iron stores by blood letting and oxidation resistance of serum lipoproteins: a randomized cross‐over trial in male smokersJournal of Internal Medicine, 1995
- Response to repeated phlebotomies in patients with non-insulin-dependent diabetes mellitusMetabolism, 1994
- IRON AND THE SEX DIFFERENCE IN HEART DISEASE RISKThe Lancet, 1981